| Schedule of Segment Reporting Information, by Segment [Table Text Block] |
| | | | | | | | | | | |
(In millions) | Seed | Crop Protection | Total | | As of and for the Year Ended December 31, 2024 | | | | | Net sales | $ | 9,545 | | $ | 7,363 | | $ | 16,908 | | | Segment operating EBITDA | 2,219 | | 1,272 | | 3,491 | | | Depreciation and amortization | 805 | | 422 | | 1,227 | | | Segment assets | 21,246 | | 14,241 | | 35,487 | | | Investments in nonconsolidated affiliates | 57 | | 77 | | 134 | | | Purchases of property, plant and equipment | 365 | | 232 | | 597 | | | As of and for the Year Ended December 31, 2023 | | | | | Net sales | $ | 9,472 | | $ | 7,754 | | $ | 17,226 | | | Segment operating EBITDA | 2,117 | | 1,374 | | 3,491 | | | Depreciation and amortization | 814 | | 397 | | 1,211 | | | Segment assets | 22,732 | | 15,004 | | 37,736 | | | Investments in nonconsolidated affiliates | 39 | | 76 | | 115 | | | Purchases of property, plant and equipment | 332 | | 263 | | 595 | | | As of and for the Year Ended December 31, 2022 | | | | | Net sales | $ | 8,979 | | $ | 8,476 | | $ | 17,455 | | | Segment operating EBITDA | 1,656 | | 1,684 | | 3,340 | | | Depreciation and amortization | 839 | | 384 | | 1,223 | | | Segment assets | 22,952 | | 14,097 | | 37,049 | | | Investments in nonconsolidated affiliates | 35 | | 67 | | 102 | | | Purchases of property, plant and equipment | 225 | | 380 | | 605 | |
Reconciliation of Segment Profitability | | | | | | | | | | | | | (In millions) | Seed | Crop Protection | Total | | For the Year Ended December 31, 2024 | | | | | Net sales | $ | 9,545 | | $ | 7,363 | | $ | 16,908 | | | Cost of goods sold | 4,876 | | 4,636 | | 9,512 | | Other expenses1 | 2,450 | | 1,455 | | 3,905 | | | Segment operating EBITDA | $ | 2,219 | | $ | 1,272 | | $ | 3,491 | | | | | | | | | | | (In millions) | Seed | Crop Protection | Total | | For the Year Ended December 31, 2023 | | | | | Net sales | $ | 9,472 | | $ | 7,754 | | $ | 17,226 | | | Cost of goods sold | 4,982 | | 4,913 | | 9,895 | | Other expenses1 | 2,373 | | 1,467 | | 3,840 | | | Segment operating EBITDA | $ | 2,117 | | $ | 1,374 | | $ | 3,491 | | | | | | | | | | | (In millions) | Seed | Crop Protection | Total | | For the Year Ended December 31, 2022 | | | | | Net sales | $ | 8,979 | | $ | 8,476 | | $ | 17,455 | | | Cost of goods sold | 4,898 | | 5,454 | | 10,352 | | Other expenses1 | 2,425 | | 1,338 | | 3,763 | | | Segment operating EBITDA | $ | 1,656 | | $ | 1,684 | | $ | 3,340 | |
|
| Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block] |
| | | | | | | | | | | | | | Income (loss) from continuing operations after income taxes to segment operating EBITDA | For the Year Ended December 31, | | | (In millions) | 2024 | 2023 | 2022 | | | Income (loss) from continuing operations after income taxes | $ | 863 | | $ | 941 | | $ | 1,216 | | | | Provision for (benefit from) income taxes on continuing operations | 412 | | 152 | | 210 | | | | Income (loss) from continuing operations before income taxes | $ | 1,275 | | $ | 1,093 | | $ | 1,426 | | | | Depreciation and amortization | 1,227 | | 1,211 | | 1,223 | | | | Interest income | (132) | | (283) | | (124) | | | | Interest expense | 233 | | 233 | | 79 | | | | Exchange (gains) losses - net | 284 | | 397 | | 229 | | | | Non-operating (benefits) costs - net | 174 | | 151 | | (111) | | | | | | | | | Mark-to-market (gains) losses on certain foreign currency contracts not designated as hedges | — | | — | | — | | | | Significant items | 315 | | 579 | | 502 | | | | Corporate expenses | 115 | | 110 | | 116 | | | | Segment operating EBITDA | $ | 3,491 | | $ | 3,491 | | $ | 3,340 | | |
|
| Schedule of Additional Segment Details [Table Text Block] |
| | | | | | | | | | | | | | | | (In millions) | Seed | Crop Protection | Corporate | Total | | For the Year Ended December 31, 2024 | | | | | Restructuring and asset related charges - net1 | $ | (55) | | $ | (142) | | $ | (91) | | $ | (288) | | Estimated settlement expense2 | — | | (101) | | — | | (101) | | Inventory write-offs3 | 2 | | — | | — | | 2 | | Gain (loss) on sale of business, assets and equity investments3 | 4 | | 3 | | — | | 7 | | Acquisition-related costs6 | — | | (6) | | — | | (6) | | Insurance proceeds7 | — | | 71 | | — | | 71 | | | Total | $ | (49) | | $ | (175) | | $ | (91) | | $ | (315) | |
| | | | | | | | | | | | | | | | (In millions) | Seed | Crop Protection | Corporate | Total | | For the Year Ended December 31, 2023 | | | | | Restructuring and asset related charges - net1 | $ | (86) | | $ | (228) | | $ | (22) | | $ | (336) | | Estimated settlement expense2 | — | | (204) | | — | | (204) | | Inventory write-offs3 | (7) | | — | | — | | (7) | | Spare parts write-off4 | — | | (12) | | — | | (12) | | Gain (loss) on sale of business, assets and equity investments3 | 4 | | 10 | | — | | 14 | | | | | | | | Employee Retention Credit | — | | 3 | | — | | 3 | | | AltEn facility remediation charges | (10) | | — | | — | | (10) | | Seed sale associated with Russia Exit3,5 | 18 | | — | | — | | 18 | | Acquisition-related costs6 | — | | (45) | | — | | (45) | | | Total | $ | (81) | | $ | (476) | | $ | (22) | | $ | (579) | |
| | | | | | | | | | | | | | | | (In millions) | Seed | Crop Protection | Corporate | Total | | For the Year Ended December 31, 2022 | | | | | Restructuring and asset related charges - net1 | $ | (228) | | $ | (37) | | $ | (98) | | $ | (363) | | Estimated settlement expense2 | — | | (87) | | — | | (87) | | Inventory write-offs3 | (33) | | — | | — | | (33) | | Gain (loss) on sale of business, assets and equity investments3 | (5) | | 15 | | — | | 10 | | Settlement costs associated with Russia Exit3 | (8) | | — | | — | | (8) | | | Employee Retention Credit | 6 | | 3 | | — | | 9 | | | AltEn facility remediation charges | (33) | | — | | — | | (33) | | Seed sale associated with Russia Exit3,5 | 3 | | — | | — | | 3 | | | Total | $ | (298) | | $ | (106) | | $ | (98) | | $ | (502) | |
1.Includes restructuring plans and asset related charges as well as accelerated prepaid amortization expense. See Note 6 - Restructuring and Asset Related Charges - Net, to the Consolidated Financial Statements, for additional information. 2.Consists of estimated Lorsban® related charges. 3.Incremental gains (losses) associated with activities related to the 2022 Restructuring Actions. 4.Incremental loss associated with activities related to the Crop Protection Operations Strategy Restructuring Program. 5.Includes a benefit of $18 million and $3 million for the years ended December 31, 2023 and 2022, respectively, relating to the sale of seeds already under production in Russia when the decision to exit the country was made and that the Company was contractually required to purchase. It consists of $71 million and $8 million of net sales and $53 million and $5 million of cost of goods sold for the years ended December 31, 2023 and 2022, respectively. 6.Relates to acquisition-related costs, including transaction and third-party integration costs associated with the completed acquisitions of Stoller and Symborg as well as the recognition of the inventory fair value step-up. See Note 4 - Business Combinations, to the Consolidated Financial Statements, for additional information. 7.Includes proceeds received related to prior significant items.
|